{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:04Z","timestamp":1788606724663,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00243810"],"award-info":[{"award-number":["RS-2023-00243810"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010955","name":"GemVax and KAEL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070671"],"award-info":[{"award-number":["RS-2022-NR070671"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13570-7","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T08:28:42Z","timestamp":1766737722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy"],"prefix":"10.1007","volume":"273","author":[{"given":"Seungmin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomseok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-2075","authenticated-orcid":false,"given":"Jee-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"4","key":"13570_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.26455","volume":"92","author":"MJ Lukic","year":"2022","unstructured":"Lukic MJ, Respondek G, Kurz C et al (2022) Long-duration progressive supranuclear palsy: clinical course and pathological underpinnings. Ann Neurol 92(4):637\u2013649. https:\/\/doi.org\/10.1002\/ana.26455","journal-title":"Ann Neurol"},{"key":"13570_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.04.014","volume":"73","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Litvan I (2020) Progressive supranuclear palsy: advances in diagnosis and management. Parkinsonism Relat Disord 73:105\u2013116. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.04.014","journal-title":"Parkinsonism Relat Disord"},{"key":"13570_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119975","volume":"565","author":"Y Chen","year":"2025","unstructured":"Chen Y, Huang J, Li Y, Chen X, Ye Q (2025) Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson\u2019s disease. Clin Chim Acta 565:119975. https:\/\/doi.org\/10.1016\/j.cca.2024.119975","journal-title":"Clin Chim Acta"},{"issue":"8","key":"13570_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90(8):870\u2013881. https:\/\/doi.org\/10.1136\/jnnp-2018-320106","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13570_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411624","author":"S Coppens","year":"2023","unstructured":"Coppens S, Lehmann S, Hopley C, Hirtz C (2023) Neurofilament-light, a promising biomarker: analytical, metrological and clinical challenges. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241411624","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13570_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000143","volume":"3","author":"J Alagaratnam","year":"2021","unstructured":"Alagaratnam J, von Widekind S, De Francesco D et al (2021) Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis. BMJ Neurol Open 3(1):e000143. https:\/\/doi.org\/10.1136\/bmjno-2021-000143","journal-title":"BMJ Neurol Open"},{"issue":"3","key":"13570_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acn3.290","volume":"3","author":"JC Rojas","year":"2016","unstructured":"Rojas JC, Karydas A, Bang J et al (2016) Plasma neurofilament light chain predicts progression in progressive supranuclear palsy. Ann Clin Transl Neurol 3(3):216\u2013225. https:\/\/doi.org\/10.1002\/acn3.290","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"13570_CR8","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1212\/WNL.0000000000004859","volume":"90","author":"JC Rojas","year":"2018","unstructured":"Rojas JC, Bang J, Lobach IV et al (2018) CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. Neurology 90(4):e273\u2013e281. https:\/\/doi.org\/10.1212\/WNL.0000000000004859","journal-title":"Neurology"},{"issue":"13","key":"13570_CR9","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","volume":"92","author":"TM Marques","year":"2019","unstructured":"Marques TM, van Rumund A, Oeckl P et al (2019) Serum NFL discriminates Parkinson disease from atypical parkinsonisms. Neurology 92(13):e1479\u2013e1486. https:\/\/doi.org\/10.1212\/WNL.0000000000007179","journal-title":"Neurology"},{"issue":"10","key":"13570_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S et al (2017) Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88(10):930\u2013937. https:\/\/doi.org\/10.1212\/WNL.0000000000003680","journal-title":"Neurology"},{"key":"13570_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","volume":"56","author":"L Donker Kaat","year":"2018","unstructured":"Donker Kaat L, Meeter LH, Chiu WZ et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinsonism Relat Disord 56:98\u2013101. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"13570_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/jnnp-2017-315857","volume":"88","author":"E Jabbari","year":"2017","unstructured":"Jabbari E, Zetterberg H, Morris HR (2017) Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers. J Neurol Neurosurg Psychiatry 88(10):883\u2013888. https:\/\/doi.org\/10.1136\/jnnp-2017-315857","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"13570_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR (2023) Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun 11(1):42. https:\/\/doi.org\/10.1186\/s40478-023-01526-9","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"13570_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.26962","volume":"96","author":"K Hirata","year":"2024","unstructured":"Hirata K, Matsuoka K, Tagai K et al (2024) In vivo assessment of astrocyte reactivity in patients with progressive supranuclear palsy. Ann Neurol 96(2):247\u2013261. https:\/\/doi.org\/10.1002\/ana.26962","journal-title":"Ann Neurol"},{"issue":"4","key":"13570_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mds.29339","volume":"38","author":"SY Huang","year":"2023","unstructured":"Huang SY, Chen SF, Cui M et al (2023) Plasma biomarkers and positron emission tomography tau pathology in progressive supranuclear palsy. Mov Disord 38(4):676\u2013682. https:\/\/doi.org\/10.1002\/mds.29339","journal-title":"Mov Disord"},{"issue":"13","key":"13570_CR16","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.3390\/ijms25136882","volume":"25","author":"CM Cristiani","year":"2024","unstructured":"Cristiani CM, Scaramuzzino L, Quattrone A, Parrotta EI, Cuda G, Quattrone A (2024) Serum oligomeric alpha-synuclein and p-tau181 in progressive supranuclear palsy and parkinson\u2019s disease. Int J Mol Sci 25(13):6882. https:\/\/doi.org\/10.3390\/ijms25136882","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13570_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1877718X241298192","volume":"15","author":"CH Li","year":"2025","unstructured":"Li CH, Fan SP, Shih MC et al (2025) Subcortical tau burden correlates with regional brain atrophy and plasma markers in four-repeat tauopathy parkinsonism. J Parkinsons Dis 15(1):214\u2013226. https:\/\/doi.org\/10.1177\/1877718X241298192","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"13570_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK et al (2021) Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol 141(5):709\u2013724. https:\/\/doi.org\/10.1007\/s00401-021-02275-6","journal-title":"Acta Neuropathol"},{"issue":"8","key":"13570_CR19","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/archneur.59.8.1267","volume":"59","author":"K Buerger","year":"2002","unstructured":"Buerger K, Zinkowski R, Teipel SJ et al (2002) Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 59(8):1267\u20131272. https:\/\/doi.org\/10.1001\/archneur.59.8.1267","journal-title":"Arch Neurol"},{"issue":"1","key":"13570_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01474-z","volume":"16","author":"D Altomare","year":"2024","unstructured":"Altomare D, Libri I, Alberici A et al (2024) Plasma biomarkers increase diagnostic confidence in patients with Alzheimer\u2019s disease or frontotemporal lobar degeneration. Alzheimers Res Ther 16(1):107. https:\/\/doi.org\/10.1186\/s13195-024-01474-z","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"13570_CR21","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41467-023-42505-x","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang L, Yang J et al (2023) Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease. Nat Commun 14(1):6670. https:\/\/doi.org\/10.1038\/s41467-023-42505-x","journal-title":"Nat Commun"},{"key":"13570_CR22","doi-asserted-by":"publisher","first-page":"1280257","DOI":"10.3389\/fcell.2023.1280257","volume":"11","author":"W Huang","year":"2023","unstructured":"Huang W, Huang J, Huang N, Luo Y (2023) The role of TREM2 in Alzheimer\u2019s disease: from the perspective of Tau. Front Cell Dev Biol 11:1280257. https:\/\/doi.org\/10.3389\/fcell.2023.1280257","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"13570_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mds.27992","volume":"35","author":"J S\u00e1nchez-Ruiz de Gordoa","year":"2020","unstructured":"S\u00e1nchez-Ruiz de Gordoa J, Erro ME, Vicu\u00f1a-Urriza J, Zelaya MV, Tellechea P, Acha B, Zueco S, Urd\u00e1noz-Casado A, Rold\u00e1n M, Blanco-Luquin I, Mendioroz M (2020) Microglia-related gene triggering receptor expressed in myeloid cells 2 (TREM2) is upregulated in the substantia nigra of progressive supranuclear palsy. Mov Disord 35(5):885\u2013890. https:\/\/doi.org\/10.1002\/mds.27992","journal-title":"Mov Disord"},{"issue":"6","key":"13570_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"issue":"6","key":"13570_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mds.26973","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Schope J, Stamelou M et al (2017) Longitudinal magnetic resonance imaging in progressive supranuclear palsy: a new combined score for clinical trials. Mov Disord 32(6):842\u2013852. https:\/\/doi.org\/10.1002\/mds.26973","journal-title":"Mov Disord"},{"key":"13570_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107301","volume":"132","author":"S Lee","year":"2025","unstructured":"Lee S, Kim H, Kim R et al (2025) Application of elastic net for clinical outcome prediction and classification in progressive supranuclear palsy: a multicenter cohort study. Parkinsonism Relat Disord 132:107301. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107301","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"13570_CR27","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1523\/JNEUROSCI.3328-08.2009","volume":"29","author":"M Beckmann","year":"2009","unstructured":"Beckmann M, Johansen-Berg H, Rushworth MF (2009) Connectivity-based parcellation of human cingulate cortex and its relation to functional specialization. J Neurosci 29(4):1175\u20131190. https:\/\/doi.org\/10.1523\/JNEUROSCI.3328-08.2009","journal-title":"J Neurosci"},{"key":"13570_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102408","volume":"28","author":"C Palmisano","year":"2020","unstructured":"Palmisano C, Todisco M, Marotta G et al (2020) Gait initiation in progressive supranuclear palsy: brain metabolic correlates. NeuroImage: Clinical 28:102408. https:\/\/doi.org\/10.1016\/j.nicl.2020.102408","journal-title":"NeuroImage: Clinical"},{"issue":"8","key":"13570_CR29","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.parkreldis.2014.05.013","volume":"20","author":"F Amtage","year":"2014","unstructured":"Amtage F, Maurer C, Hellwig S et al (2014) Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: an FDG-PET study. Parkinsonism Relat Disord 20(8):898\u2013906. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.05.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"13570_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5414\/npp28046","volume":"28","author":"RA Armstrong","year":"2009","unstructured":"Armstrong RA, Lantos PL, Cairns NJ (2009) Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 28(1):46\u201353. https:\/\/doi.org\/10.5414\/npp28046","journal-title":"Clin Neuropathol"},{"issue":"1","key":"13570_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","volume":"120","author":"O Yokota","year":"2010","unstructured":"Yokota O, Davidson Y, Bigio EH et al (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120(1):55\u201366. https:\/\/doi.org\/10.1007\/s00401-010-0702-1","journal-title":"Acta Neuropathol"},{"key":"13570_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2018.02.004","volume":"49","author":"M Seki","year":"2018","unstructured":"Seki M, Seppi K, Mueller C et al (2018) Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy. Parkinsonism Relat Disord 49:81\u201387. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.004","journal-title":"Parkinsonism Relat Disord"},{"key":"13570_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.nicl.2017.09.008","volume":"16","author":"JA Brown","year":"2017","unstructured":"Brown JA, Hua AY, Trujllo A et al (2017) Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy. Neuroimage Clin 16:564\u2013574. https:\/\/doi.org\/10.1016\/j.nicl.2017.09.008","journal-title":"Neuroimage Clin"},{"issue":"2","key":"13570_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa194","volume":"2","author":"NY Tse","year":"2020","unstructured":"Tse NY, Chen Y, Irish M et al (2020) Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy. Brain Commun 2(2):fcaa194. https:\/\/doi.org\/10.1093\/braincomms\/fcaa194","journal-title":"Brain Commun"},{"issue":"3","key":"13570_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiol.12120364","volume":"267","author":"G Nicoletti","year":"2013","unstructured":"Nicoletti G, Rizzo G, Barbagallo G et al (2013) Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology 267(3):843\u2013850. https:\/\/doi.org\/10.1148\/radiol.12120364","journal-title":"Radiology"},{"issue":"1","key":"13570_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf051","volume":"7","author":"C Spiegel","year":"2025","unstructured":"Spiegel C, Marotta C, Bertram K, Vivash L, Harding IH (2025) Brainstem and cerebellar radiological findings in progressive supranuclear palsy. Brain Commun 7(1):fcaf051. https:\/\/doi.org\/10.1093\/braincomms\/fcaf051","journal-title":"Brain Commun"},{"key":"13570_CR37","doi-asserted-by":"publisher","first-page":"1240709","DOI":"10.3389\/fnins.2023.1240709","volume":"17","author":"JH Ahn","year":"2023","unstructured":"Ahn JH, Kwon J, Won JH et al (2023) Waiting impulsivity in progressive supranuclear palsy-Richardson\u2019s syndrome. Front Neurosci 17:1240709. https:\/\/doi.org\/10.3389\/fnins.2023.1240709","journal-title":"Front Neurosci"},{"key":"13570_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neurobiolaging.2022.02.007","volume":"113","author":"SE Burke","year":"2022","unstructured":"Burke SE, Phillips JS, Olm CA et al (2022) Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology. Neurobiol Aging 113:95\u2013107. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.02.007","journal-title":"Neurobiol Aging"},{"issue":"50","key":"13570_CR39","doi-asserted-by":"publisher","first-page":"12688","DOI":"10.1523\/JNEUROSCI.1175-16.2016","volume":"36","author":"S Hu","year":"2016","unstructured":"Hu S, Ide JS, Zhang S, Li CR (2016) The right superior frontal gyrus and individual variation in proactive control of impulsive response. J Neurosci 36(50):12688\u201312696. https:\/\/doi.org\/10.1523\/JNEUROSCI.1175-16.2016","journal-title":"J Neurosci"},{"issue":"11","key":"13570_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080353","volume":"8","author":"J Lagarde","year":"2013","unstructured":"Lagarde J, Valabregue R, Corvol JC et al (2013) Are frontal cognitive and atrophy patterns different in PSP and bvFTD? A comparative neuropsychological and VBM study. PLoS ONE 8(11):e80353. https:\/\/doi.org\/10.1371\/journal.pone.0080353","journal-title":"PLoS ONE"},{"issue":"1","key":"13570_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00562-8","volume":"17","author":"B Zhu","year":"2022","unstructured":"Zhu B, Liu Y, Hwang S et al (2022) Trem2 deletion enhances tau dispersion and pathology through microglia exosomes. Mol Neurodegener 17(1):58. https:\/\/doi.org\/10.1186\/s13024-022-00562-8","journal-title":"Mol Neurodegener"},{"issue":"1","key":"13570_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00415-024-12747-w","volume":"272","author":"F Maass","year":"2024","unstructured":"Maass F, Canaslan S, van Riesen C et al (2024) Myelin basic protein and TREM2 quantification in the CSF of patients with multiple system atrophy and other Parkinsonian conditions. J Neurol 272(1):52. https:\/\/doi.org\/10.1007\/s00415-024-12747-w","journal-title":"J Neurol"},{"issue":"11","key":"13570_CR43","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1515\/cclm-2022-0646","volume":"60","author":"L Tybirk","year":"2022","unstructured":"Tybirk L, Hviid CVB, Knudsen CS, Parkner T (2022) Serum GFAP - reference interval and preanalytical properties in Danish adults. Clin Chem Lab Med 60(11):1830\u20131838. https:\/\/doi.org\/10.1515\/cclm-2022-0646","journal-title":"Clin Chem Lab Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13570-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13570-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13570-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:58:24Z","timestamp":1773665904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13570-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13570"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13570-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"50"}}